Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce.

Authors:
White H; McDonald SJ; Barber B; Davis J; Burr L and 6 more

Journal:
Med J Aust

Publication Year: 2022

DOI:
10.5694/mja2.51718

PMCID:
PMC9538623

PMID:
36150213

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Med J Aust

Abbreviation: Med J Aust

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Access to voluntary assisted dying in Australia requires fair remuneration for medical practitioner…
Haining CM; Willmott L; Towler S and 1 more (2022) - Transparency Score: 3/6
A planetary health-organ system map to integrate climate change and health content into medical cur…
Burch H; Beaton LJ; Simpson G and 3 more (2022) - Transparency Score: 2/6
A polymorphic rash from across the seas.
Flora A; Garg P; Cheung K and 2 more (2022) - Transparency Score: 2/6
Assessing the value of precision medicine health technologies to detect and manage melanoma.
Mahumud RA; Janda M; Soyer HP and 3 more (2022) - Transparency Score: 3/6
Associations between COVID-19 and hospitalisation with respiratory and non-respiratory conditions: …
Rowe SL; Leder K; Dyson K and 10 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests No relevant disclosures."

Evidence found in paper:

"The National COVID‐19 Clinical Evidence Taskforce is funded by the Australian Department of Health, the Victorian Department of Health and Human Services, the Ian Potter Foundation and the Walter Cottman Endowment Fund (managed by Equity Trustees), and the Lord Mayors’ Charitable Foundation. We thank all members of the National COVID‐19 Clinical Evidence Taskforce for their magnificent contributions to the work described in this article, and acknowledge the Taskforce member organisations and our partners (complete list included in the Supporting Information)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025